These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2237935)
1. In vitro immunotoxicology and immunopharmacology: studies on drugs of abuse. Pillai RM; Watson RR Toxicol Lett; 1990 Oct; 53(3):269-83. PubMed ID: 2237935 [TBL] [Abstract][Full Text] [Related]
2. 'In vitro immunotoxicology and immunopharmacology: studies on drugs of abuse' by R.M. Pillai and R.R. Watson. Donahoe RM Toxicol Lett; 1990 Oct; 53(3):265-8. PubMed ID: 2237934 [No Abstract] [Full Text] [Related]
3. Procedures available to examine the immunotoxicity of chemicals and drugs. Dean JH; Luster MI; Boorman GA; Lauer LD Pharmacol Rev; 1982 Mar; 34(1):137-48. PubMed ID: 6280211 [TBL] [Abstract][Full Text] [Related]
4. AIDS, drugs of abuse and the immune system: a complex immunotoxicological network. Pillai R; Nair BS; Watson RR Arch Toxicol; 1991; 65(8):609-17. PubMed ID: 1747059 [TBL] [Abstract][Full Text] [Related]
5. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals. Dean JH Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200 [TBL] [Abstract][Full Text] [Related]
6. Present and future of in vitro immunotoxicology in drug development. Galbiati V; Mitjans M; Corsini E J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150 [TBL] [Abstract][Full Text] [Related]
7. Immunotoxicology of opioids, inhalants, and other drugs of abuse. House RV; Thomas PT; Bhargava HN NIDA Res Monogr; 1997; 173():175-200. PubMed ID: 9260189 [No Abstract] [Full Text] [Related]
9. Immunotoxicology: An overview. Dean JH Toxicol In Vitro; 1994 Oct; 8(5):933-7. PubMed ID: 20693049 [TBL] [Abstract][Full Text] [Related]
10. Immunotoxicology: an overview. Dean JH; Thurmond LM Toxicol Pathol; 1987; 15(3):265-71. PubMed ID: 3317766 [TBL] [Abstract][Full Text] [Related]
11. Addictive drugs and their relationship with infectious diseases. Friedman H; Pross S; Klein TW FEMS Immunol Med Microbiol; 2006 Aug; 47(3):330-42. PubMed ID: 16872369 [TBL] [Abstract][Full Text] [Related]
12. Immunotoxicology in the pharmaceutical industry. Norbury KC Environ Health Perspect; 1982 Feb; 43():53-9. PubMed ID: 7037389 [TBL] [Abstract][Full Text] [Related]
13. AIDS, drugs of abuse and the neuroimmune axis: introduction and perspectives. Friedman H Adv Exp Med Biol; 1996; 402():1-3. PubMed ID: 8787636 [No Abstract] [Full Text] [Related]
17. What are the prospects for regulation in immunotoxicology? Hastings KL Toxicol Lett; 1998 Dec; 102-103():267-70. PubMed ID: 10022264 [TBL] [Abstract][Full Text] [Related]
18. Testing strategies in immunotoxicology. Pallardy M; Kerdine S; Lebrec H Toxicol Lett; 1998 Dec; 102-103():257-60. PubMed ID: 10022262 [TBL] [Abstract][Full Text] [Related]
19. Immunological aspects of toxicology: premises not promises. Yoshida S; Golub MS; Gershwin ME Regul Toxicol Pharmacol; 1989 Feb; 9(1):56-80. PubMed ID: 2667038 [TBL] [Abstract][Full Text] [Related]
20. Application of metabolomics to toxicology of drugs of abuse: A mini review of metabolomics approach to acute and chronic toxicity studies. Zaitsu K; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A Drug Metab Pharmacokinet; 2016 Feb; 31(1):21-26. PubMed ID: 26613805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]